S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
TSE:XBC

Xebec Adsorption (XBC) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
C$0.51
C$0.51
52-Week Range
N/A
Volume
337,870 shs
Average Volume
709,980 shs
Market Capitalization
C$78.91 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
XBC stock logo

About Xebec Adsorption Stock (TSE:XBC)

Xebec Adsorption Inc. designs, manufactures, and sells purification, separation, dehydration, and filtration equipment for gases and compressed air in Canada, the United States, China, Korea, Italy, France, and internationally. It operates through Systems and Support segments. The company offers on-site air dehydration under the ADX Solutions brand; biogas to renewable natural gas systems under the BGX Solutions brand; hydrogen purification systems under the H2X Solutions brand; natural gas dehydration units for refueling stations under the NGX Solutions brand; and products for the filtration and separation of air and gases under FSX Solutions brand. It also provides steam methane reforming products for production of hydrogen from natural gas under the Hy.GEN brand; electrolysis products for production of hydrogen from electricity under the Hy.GEN-e brand; on-site oxygen and nitrogen generators; industrial process chillers; fluid savers and pumping stations; compressed air and gas dryers and filters; and spare parts and replacement filter elements; dew-point probes and calibration services. Xebec Adsorption Inc. was founded in 1967 and is headquartered in Blainville, Canada.

XBC Stock News Headlines

Xebec Adsorption (TSE:XBC) Stock Price Up 2%
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
XBC/USD - Bitcoin Plus US Dollar
Xebec Adsorption Inc. (XEBEQ)
XBC.TO - | Stock Price & Latest News | Reuters
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Xebec Announces Q2 2022 Financial Results
Xebec Adsorption Inc stock advanced on Tuesday.
Xebec Adsorption Inc stock decreased on Tuesday.
Xebec Announces Q4 and Year End 2021 Financial Results
Xebec Announces Board Resignation of Karen Nielsen
3 Spooky Stocks I Own: What Should I Do?!
See More Headlines
Receive XBC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Xebec Adsorption and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Specialty Industrial Machinery
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
600
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$155.36 million
Book Value
C$1.68 per share

Miscellaneous

Free Float
N/A
Market Cap
C$78.91 million
Optionable
Not Optionable
Beta
N/A
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Dimitrios Vounassis
    Pres, CEO & Director
  • Mr. Stephane Dephane Archambault C.M.A.
    CPA, Chief Financial Officer
  • Ms. Nathalie Theberge L.L.B.
    LL.B, Chief Legal Officer & Corp. Sec.
  • Mr. Marinus Van Driel
    Pres of Europe & Global Hydrogen Group
  • Mr. Mike Munro
    Chief Operating Officer
  • Brandon Chow
    Director of Investor Relations
  • Mr. Antonio Saavedra
    Director of Sales & Bus. Devel.
  • Ms. Vanessa de Bonville
    Director of HR & EHS
  • Mr. Claude Pouliot
    Corp. Controller
  • Dr. Peter Cheng
    Gen. Mang. of Xebec Adsorption Shanghai Co Ltd

XBC Stock Analysis - Frequently Asked Questions

How do I buy shares of Xebec Adsorption?

Shares of XBC stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (TSE:XBC) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners